In the 1990s several big pharmaceutical firms, including Bayer AG of Germany, Eli Lilly and Pfizer, formed alliances with Chinese research institutes or companies that specialized in traditional Chinese medicines, aiming to apply modern drug-hunting techniques to screen Chinese herbal medicines for potential Western blockbusters.
FORBES: Magazine Article